Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
RNTX
TXMD
Add up to 3 more stocks
RNTX
Rein Therapeutics Inc.
0.00%
$0.820.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$23.06M
52W Range
$0.69 - $2.18
TXMD
TherapeuticsMD, Inc.
+0.50%
$2.02+0.01Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$23.38M
52W Range
$1.03 - $2.95
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 11.88 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.26 | 0.86 |
| P/S Ratio | N/A | 7.15 |
| P/FCF Ratio | N/A | 7.49 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 100.0% |
| Operating Margin | 0.0% | -139.4% |
| Net Margin | 0.0% | -6.6% |
| ROE | -487.9% | -0.8% |
| ROA | -75.4% | -0.6% |
| ROIC | -36.9% | -11.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.27 | 3.22 |
| Quick Ratio | 4.27 | 3.22 |
| Debt/Equity | 0.00 | 0.20 |
| Interest Coverage | N/A | -526.75 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.